OWLT

Owlet, Inc.
CAPPED RATING

Owlet, Inc. (OWLT) is rated C (2.4/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B); its weakest is Momentum (D+).

Quantitative Factor Evaluation • Updated

Overall Rating
2.4 / 5.0
C
Value
B
Factor Score 3.2 / 5.0
Growth
C
Factor Score 2.2 / 5.0
Profitability
C
Factor Score 2.4 / 5.0
Momentum
D+
Factor Score 1.6 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 15.6
EV / EBITDA -12.8
Rev Growth YoY 29.9%
Gross Margin 54.6%
Price Return 3M -43.7%
Price Return 12M -68.7%
Catalyst Signal 0.00
Market Cap $100.5M
TTM Revenue $114.4M
Price / Sales 0.9
ROE N/A

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-14 B (3.2) C (2.2) C (2.4) D+ (1.6) C+ (2.6) C (2.4)
2026-11-07 B- (3.1) C (2.3) C (2.4) C- (2.1) C+ (2.7) C+ (2.5)
2026-10-31 B (3.2) C (2.3) C+ (2.6) C (2.3) C+ (2.7) C+ (2.6)
2026-10-24 B- (3.1) C (2.2) C+ (2.5) C- (2.1) C+ (2.6) C+ (2.5)
2026-10-17 B- (3.1) C (2.2) C+ (2.5) D+ (1.7) C+ (2.6) C (2.5)
Page 1 of 4